Bristol-Myers Squibb Company and Celgene Corporation announced that they have entered into a merger agreement under which Bristol-Myers Squibb will acquire Celgene in a cash and stock transaction with an equity value of approximately $74 billion.
» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favoarite shows, exclusive video and more.
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Find CNBC News on Facebook: http://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC
Follow CNBC News on Google+: http://cnb.cx/PlusCNBC
Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC
#CNBC
acquisition
Bristol-Myers to buy Celgene in $74B deal | |
| 567 views views | 86,888 followers |
| 12 Likes | 12 Dislikes |
| News & Politics | Upload TimePublished on 3 Jan 2019 |
